Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Third Quarter Healthcare Activity Rebounds
Despite a tumultuous summer in the United States, healthcare M&A activity rebounded in the third quarter, hitting 524 deals across the 17 sectors tracked by LevinPro HC. Compared with the second quarter, activity levels increased roughly 6%, and year-over-year activity is effectively the same, with only a 1% difference in deal volume. These margins are likely to widen once deals and transactions are reported in upcoming quarterly reports and filings, however. Spending skyrocketed, hitting $63.8 billion, more than double the $30 billion from the second quarter and 35% higher than the $47.09 billion spent in Q3:24. The largest deal was Waters Corporation’s $17.5... Read More »
Cardinal Health Strikes $1.9 Billion Deal for Solaris Health
Cardinal Health, the global healthcare conglomerate, has made another large push into the healthcare provider space. On August 12, through its subsidiary The Specialty Alliance, Cardinal Health bought Solaris Health in a $1.9 billion deal, its fifth deal since the start of 2024. Solaris Health is one of the largest urology and management service organizations in the United States, with more member physicians than any other provider of urological and specialty services. Its physicians span 14 states (Colorado, Florida, Georgia, Illinois, Indiana, Kentucky, Maryland, Michigan, New York, North Carolina, Ohio, Pennsylvania, South Carolina and Washington), with more than 750... Read More »
Megadeals in Healthcare: A 2025 Mid-Year Review and Outlook
Healthcare megadeals, defined as transactions valued at $1 billion or more, slowed notably in the first half of 2025, according to data captured in the LevinPro database. There were 18 megadeals announced during the first half of 2025, a 33% decline from the 27 deals announced during the same period of 2024. The decline marks the lowest mid-year tally since 2020 and continues a downward trend from the 30 megadeals announced in the first half of 2022 and 19 in the first half of 2023. While the billion-dollar threshold was still crossed multiple times across the Biotechnology, Pharmaceutical, eHealth, Medical Devices and more sectors, the pace of activity suggests growing caution among... Read More »
Healthcare M&A Remained Steady in First Half of 2025
Healthcare merger and acquisition (M&A) activity remained nearly steady in the first half of 2025, with 1,020 deals announced, according to data from the LevinPro HC platform. This represents a slight decrease compared to 1,025 transactions announced in the first half of 2024. The difference in quarter-over-quarter activity was more pronounced in the second quarter of 2025, with 489 deals announced, marking an 8% drop from the 531 transactions in the first quarter of 2025, and a 4% decrease from the 511 deals in Q2:24. Disclosed spending in Q2:25 totaled $30 billion, a 55% decrease from $66.4 billion in Q1:25, and down 41% from $50.8 billion in Q2:24. For the first half of 2025,... Read More »
